Hospital Stocks Rally on Failed Obamacare Repeal
The demise of an attempt to eliminate and replace the Affordable Care Act is good news for hospital operators.
The collapse of GOP efforts to repeal Obamacare will cut across many sectors. Whether it's good news or bad news depends on which stocks you own. Some parts of the health care industry would have been hurt by the passage of the American Health Care Act (AHCA), the Republican alternative. But no group of stocks has rallied in relief like hospital operators. Here are two hospital stocks to consider buying after the death of the AHCA, and one to ignore:
Tenet Healthcare (symbol THC)
Shares in the hospital company jumped as much as 8% in early trading before settling down to more modest gains. There were reasons to be optimistic about Tenet even before repeal and replace failed, so these gains have a chance of sticking.
The company's acquisitions of three other health care providers in 2015 have exceeded expectations. UBS analyst A.J. Rice rates shares at "buy," citing the company's focus on smaller projects with faster payback. The analysts' target price of $24 implies a gain of 29% in the next 12 months or so.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Analysts note that even if the AHCA passed and did away with public health care exchanges, it would have hurt the company's admissions by only about 1%.
Universal Health Services (UHS)
Shares in Universal Health Services rose as much as 5.4% quickly after the opening bell on Mar. 27, after the failure of the AHCA prompted some analysts to upgrade their ratings.
Japan's Mizuho Equity Research upgraded UHS to "buy" from "neutral" (hold, essentially) now that it has moved into a "nicer, friendlier neighborhood, one that includes continuation of the important benefit of the Medicaid expansion and without a near- or medium-term threat of block grants."
With the overhang of changes to the health care system removed, the analysts say the stock is undervalued based on its strong volume of patients and free cash flow generation. Of the 11 United Health analysts followed by Zacks, seven recommend it as a strong buy, while four say it's a "hold."
Community Health Systems (CYH)
Shares in Community Health jumped as much as 6% after the Mar. 27 opening bell. It was just the latest boost for a stock that is having a good year after a prolonged series of woes. In the last 3 years, Community Health has been forced to settle with Justice Department over billing practices, been the victim of a hacking attack, and paid $1.9 million to settle a lawsuit brought by a whistleblower.
Although Community Health is rising after the demise the AHCA, some analysts worry the outperformance won't last. Credit Suisse rates shares at "underperform" (sell, essentially), in part because the company is being forced to sell off facilities in order to pay down heavy levels of debt. Rising expenses and tough comparisons with last year's results will also weigh in the stock, Credit Suisse says.
Things could have soured quickly for hospital operators if the AHCA passed the House. The Congressional Budget Office estimated that the measure would result in 14 million fewer Americans with insurance by 2018. An additional 24 million people were to be without insurance over the next decade, CBO estimated. These are the hospital industry's paying customers. Investors here can breathe a sigh of relief.
Make no mistake, however, that the threat to the sector hasn't disappeared completely. Credit Suisse analysts expect to see attempts at incremental changes to ObamaCare instead. "We do not yet have a line of sight into how these potential changes may unfold," writes analyst Scott Fidel.
That means lingering uncertainty. Another risk to keep in mind is that it can be a bad idea to buy stocks when they're rallying. The idea is to buy low, after all. That's not to say that investors should avoid all hospital stocks in wake of the latest developments. But they should be selective.
To continue reading this article
please register for free
This is different from signing in to your print subscription
Why am I seeing this? Find out more here
Dan Burrows is Kiplinger's senior investing writer, having joined the august publication full time in 2016.
A long-time financial journalist, Dan is a veteran of SmartMoney, MarketWatch, CBS MoneyWatch, InvestorPlace and DailyFinance. He has written for The Wall Street Journal, Bloomberg, Consumer Reports, Senior Executive and Boston magazine, and his stories have appeared in the New York Daily News, the San Jose Mercury News and Investor's Business Daily, among other publications. As a senior writer at AOL's DailyFinance, Dan reported market news from the floor of the New York Stock Exchange and hosted a weekly video segment on equities.
Once upon a time – before his days as a financial reporter and assistant financial editor at legendary fashion trade paper Women's Wear Daily – Dan worked for Spy magazine, scribbled away at Time Inc. and contributed to Maxim magazine back when lad mags were a thing. He's also written for Esquire magazine's Dubious Achievements Awards.
In his current role at Kiplinger, Dan writes about equities, fixed income, currencies, commodities, funds, macroeconomics, demographics, real estate, cost of living indexes and more.
Dan holds a bachelor's degree from Oberlin College and a master's degree from Columbia University.
Disclosure: Dan does not trade stocks or other securities. Rather, he dollar-cost averages into cheap funds and index funds and holds them forever in tax-advantaged accounts.
-
After Decades of Promise, the Virtual Reality Era Has Finally Arrived
The Kiplinger Letter VR is a paradigm shift for consumer technology. The tech has a long road ahead, but amazing hardware already puts the huge potential on full display.
By John Miley Published
-
Fed Rate Cuts Still on Hold
The Kiplinger Letter With inflation stubbornly elevated, the Federal Reserve will keep interest rates high for now.
By David Payne Published
-
Stock Market Today: Nasdaq Pops as Semiconductor Stocks Soar
The main indexes closed higher Monday after a bull call on Micron boosted several large-cap chipmakers.
By Karee Venema Published
-
Stock Market Today: Stocks Soar on Apple Buyback News, Jobs Data
The main indexes rallied hard to end the week thanks to Apple's $110 billion stock repurchase plan and a big April payrolls miss.
By Karee Venema Published
-
Stock Market Today: Stocks Sizzle Ahead of Apple Earnings, Jobs Report
The Nasdaq outperformed in a strong day for stocks thanks to Qualcomm's post-earnings pop.
By Karee Venema Published
-
Stock Market Today: Stocks Pop Then Drop After Fed Meeting
Stocks went on a roller-coaster ride after Fed Chair Powell said interest rates were likely at a sufficiently restrictive level.
By Karee Venema Published
-
Stock Market Today: Stocks Sell Off Ahead of Fed Decision
Stocks sold off sharply Tuesday as anxiety set in ahead of Wednesday's policy statement from the Federal Reserve.
By Karee Venema Published
-
Stock Market Today: Markets Post Broad-Based Gains Thanks to Mega-Cap Tech
Stocks get help from a couple of laggard Magnificent 7 stocks.
By Dan Burrows Published
-
Stock Market Today: Markets Soar Amid Strong Earnings for Big Tech
Equities ended the week on an up note thanks to some of the market's biggest names.
By Dan Burrows Published
-
Stock Market Today: Markets Tumble Amid Slower Economic Growth and Rising Prices
Disappointing readings on GDP and inflation helped tank equities.
By Dan Burrows Published